ArticleResearch square2024

Anti-tumor Effects of the eIF4A Inhibitor Didesmethylrocaglamide and Its Derivatives in Human and Canine Osteosarcomas.

Janet Oblinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.